Top Trends Transforming the Specialty Generics Market Landscape in 2025: New Approval To Address The Critical Need For Medication

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Will the Specialty Generics Industry Market Size Be by 2025?
In recent times, the specialty generics market has witnessed swift expansion. The market is projected to surge from a valuation of $95.87 billion in 2024 to $108.11 billion in 2025, marking a compound annual growth rate (CAGR) of 12.8%. This market expansion during the previous period is primarily due to the expiry of patented brand-name medications, increasing preference for budget-friendly substitutes, regulatory endorsement of generic drug approvals, escalating healthcare expenditure pressures, growth in chronic illnesses, and an uptick in the elderly population.

What's the Long-Term Growth Forecast for the Specialty Generics Market Size Through 2029?
The size of the specialty generics market is predicted to see significant expansion in the upcoming years, reaching $189.72 billion by 2029 with a compound annual growth rate (CAGR) of 15.1%. Factors contributing to this surge in the forecasted period include the growth of the biosimilars market, a focus on developing complex generic drugs, an increased emphasis on specialty generic injectables, the use of 3D printing in specialty generic manufacturing, and the rise of specialty generics in developing markets. Key trends for the projected period encompass personalized and targeted specialty generics, strategic alliances, and partnerships in generic drug development, attention on creating abuse-deterrent formulations, the incorporation of digital health technologies in specialty generics, and regulatory procedures for fast-tracked approval of complex generics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

What Are the Key Growth Drivers Fueling the Specialty Generics Market Expansion?
The rise in chronic illnesses is anticipated to boost the specialty generic market's demand. These enduring diseases can often be impossible to cure, although they can sometimes be treated and managed. Factors contributing to chronic conditions include changes in lifestyle, eating habits, and failure to maintain a healthy body weight. Additionally, certain prolonged chronic infections can pose a risk of cancer. The increasing exposure to these illnesses enhances the need for specialty generic to help patients manage complex chronic diseases. For example, in September 2022, the World Health Organization, a Switzerland-based specialised agency of the United Nations, reported that there were 41 million deaths around the globe, accounting for 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Hence, the rise in chronic diseases is fuelling the growth of the specialty generic market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp

What Are the Key Trends Driving Specialty Generics Market Growth?
Major firms in the specialty generic market, such as Lisdexamfetamine Dimesylate, are securing approvals to meet the urgent requirement for medication. In the world of specialty generics, obtaining regulatory affirmation is crucial. This affirmation legitimizes pharmaceutical items that are bioequivalent and therapeutically comparable to trademarked specialty drugs, specifically ones used in treating complex or rare medical problems, once their patents are expired. In August 2023, for example, Mallinckrodt plc, a specialty pharmaceutical firm based in Ireland, garnered FDA approval for its Lisdexamfetamine Dimesylate Capsules in the SpecGx LLC Specialty Generics portion of the market. This approval allows for treating Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine Dimesylate is a particular type of specialty generic, and it's also classified as a federally controlled substance (CII), used for ADHD treatment and several other indications.

How Is the Specialty Generics Market Segmented?
The specialty generics market covered in this report is segmented -

1) By Route Of Administration: Injectables, Oral, Other Route Of Administration
2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication
3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmaciesx

Subsegments:
1) By Injectables: Intravenous (IV) Injectables, Intramuscular (IM) Injectables, Subcutaneous (SC) Injectables
2) By Oral: Tablets, Capsules, Liquid Formulations
3) By Other Route Of Administration: Topical, Transdermal, Inhalation

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7781&type=smp

Which Companies Are Leading the Charge in Specialty Generics Market Innovation?
Major companies operating in the specialty generics market include Teva Pharmaceutical Industries Ltd., Endo International plc, Akorn Operating Company LLC, Mallinckrodt Pharmaceuticals, Dr. Reddy's Laboratories Ltd., Fresenius Kabi Brasil Ltda, STADA Arzneimittel AG, Cipla Limited, Lupin Ltd, Aurobindo Pharma Limited, Aspen Pharmacare Holdings Limited, Pfizer Inc., Accord Healthcare Limited, Amneal Pharmaceuticals Inc., Sandoz International GmbH, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Impax Laboratories Inc., Par Pharmaceutical Companies Inc., Alvogen, Alkem Laboratories Ltd., Wockhardt Ltd., Strides Pharma Science Limited, Indoco Remedies Ltd., Unichem Laboratories Ltd., Alembic Pharmaceuticals Ltd., Jubilant Life Sciences Ltd.

Which Regions Are Leading the Global Specialty Generics Market in Revenue?
North America was the largest region in the specialty generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7781

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.